ASON-DNAzyme Complex 28. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK (2011) RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11: 59–67. 29. Perrimon N, Ni JQ, Perkins L (2010) In vivo RNAi: today and tomorrow. Cold Spring Harb Perspect Biol 2: a003640. 30. Liu Q, Paroo Z (2010) Biochemical principles of small RNA pathways. Annu Rev Biochem 79: 295–319. 31. Breaker RR (2004) Natural and engineered nucleic acids as tools to explore biology. Nature 432: 838–845. 32. Chan SH, Stoddard BL, Xu SY (2011) Natural and engineered nicking endonucleases—from cleavage mechanism to engineering of strand-specificity. Nucleic Acids Res 39: 1–18. 33. Franzen S (2010) Expanding the catalytic repertoire of ribozymes and deoxyribozymes beyond RNA substrates. Curr Opin Mol Ther 12: 223– 232. 34. Dass CR, Saravolac EG, Li Y, Sun L-Q (2002) Cellular uptake, distribution and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev 12: 289–299. 35. Schubert S, Gul DC, Grunert HP, Zeichhardt H, Erdmann VA, et al. (2003) RNA cleaving ‘‘10-23’’ DNAzymes with enhanced stability and activity. Nucleic Acids Res 31: 5982–5992. 36. Werner M, Uhlenbeck OC (1995) The effect of base mismatches in the substrate recognition helices of hammerhead ribozymes on binding and catalysis. Nucleic Acids Res 23: 2092–2096. 37. Lam JC, Withers JB, Li Y (2010) A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction. Journal of molecular biology 23;400(4): 689–701. 38. Wong JP, Christopher ME, Salazar AM, Sun LQ, Viswanathan S, et al. (2010) Broad-spectrum and virus-specific nucleic acid-based antivirals against influen- za. Front Biosci (Schol Ed) 2: 791–800. 39. Schlosser K, Li Y (2009) DNAzyme-mediated catalysis with only guanosine and cytidine nucleotides. Nucleic Acids Res 37(2): 413–420. 40. Mastroyiannopoulos NP, Uney JB, Phylactou LA (2010) The application of ribozymes and DNAzymes in muscle and brain. Molecules 15: 5460–5472. 41. Bennett CF, Chiang MY, Chan H, Shoemaker JE, Mirabelli CK (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41: 1023–1033. 42. Schubert S, Kurreck J (2004) Ribozyme- and deoxyribozyme-strategies for medical applications. Curr Drug Targets 5: 667–81. 43. Tong-Hong Wang, Wan-Ting Li, Szu-Hsien Yu, Lo-Chun Au (2008) The Use of 10-23 DNAzyme to Selectively Destroy the Allele of mRNA with a Unique Purine-Pyrimidine Dinucleotide. Oligonucleotides 18(3): 295–300. PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18629